Underlying Volume Growth (UVG)
6%
+6pp YoY
Highest quarterly volume growth in 12 quarters, driven by market development and channel expansion.
HINDUNILVR
Consumer
13 Apr 2026
Hindustan Unilever Ltd — Q4 FY26
HUL delivered 8% revenue growth in Q4 FY26, the highest in 12 quarters, driven by 7% underlying sales growth led by volumes.
✓ Verified against BSE filing
2-Min Summary
✦ AI-Generated from Full Transcript
HUL delivered 8% revenue growth in Q4 FY26, the highest in 12 quarters, driven by 7% underlying sales growth led by volumes. EBITDA margin at 23.7% came at the higher end of guidance, with PAT before exceptional items at ₹2,711 crore (+4% YoY). Growth was broad-based across segments, with home care and beauty & well-being leading. Management highlighted strong execution in quick commerce, premiumization in personal care, and a turnaround in lifestyle nutrition. For FY27, they expect better performance than FY26 despite geopolitical volatility and input cost inflation of 8-10%. Medium-term margin guidance remains 22.5-23.5%. Key risk: sustained crude inflation and currency depreciation could pressure margins and require further pricing actions.
Key Numbers
Liquids Portfolio Turnover
₹4,000 Cr
+double-digit YoY
Home care liquids crossed ₹4,000 crore turnover, gaining market share through format innovation.
Beauty & Well-being ARR
₹1,200 Cr
+quadrupled YoY
Beauty and well-being portfolio quadrupled over the last year, now at ₹1,200 crore annual run rate.
Body Wash Market Share Gain
400 bps
+400bps YoY
Body wash gained 400 basis points market share, driven by premiumization and market development.
Management Guidance
FY27 to be better than FY26
Management expects FY27 performance to exceed FY26, driven by portfolio transformation and execution improvements.
Management guidance growthMedium-term EBITDA margin guidance 22.5-23.5%
Margin guidance maintained at 22.5-23.5% for the medium term, with flexibility to operate at lower end if cost pressures persist.
Management guidance marginsPrice increases of 2-5% already taken
Calibrated price increases of 2-5% implemented across home care and personal care to offset input cost inflation.
Management guidance revenue₹2,000 crore capex in premium formats
Capital investment of ₹2,000 crore planned for expanding capacity in premium formats across home care, personal care, and beauty.
Management guidance capexKey Risks
Sustained crude inflation and currency depreciation
Crude-linked commodity costs and rupee depreciation could increase input costs beyond current 8-10% inflation, pressuring margins.
high · management_commentaryEl Niño impact on rural demand
Below-normal monsoon forecast (92%) could affect rural incomes and demand, though reservoir levels and MSPs provide some buffer.
medium · analyst_questionCompetitive intensity limiting pricing power
If competitors do not follow price hikes, HUL may need to absorb cost inflation or lose market share, potentially impacting margins.
medium · analyst_questionMass skincare portfolio drag
Mass skincare (Glow & Lovely, talcum powders) remained subdued, weighing on overall beauty segment growth despite premium strength.
low · data_observationNotable Quotes
Our number one priority will be to protect our competitiveness and our consumer franchise and to strengthen our consumer franchise and in that sense drive profit through revenue accretion.
We are confident of fiscal year 27 to be better than fiscal year 26 despite all the volatility that we are seeing in the market.
The real opportunity to educate India on what is required in skincare... is sunscreens and sun protection is required and therefore educating and making it accessible.
Frequently Asked Questions
What was HUL's revenue in Q4 FY26?
HUL reported revenue of ₹16,351 Cr in Q4 FY26, representing a +8% change compared to the same quarter last year.
What guidance did HUL management give for FY27?
FY27 to be better than FY26: Management expects FY27 performance to exceed FY26, driven by portfolio transformation and execution improvements. Medium-term EBITDA margin guidance 22.5-23.5%: Margin guidance maintained at 22.5-23.5% for the medium term, with flexibility to operate at lower end if cost pressures persist. Price increases of 2-5% already taken: Calibrated price increases of 2-5% implemented across home care and personal care to offset input cost inflation. ₹2,000 crore capex in premium formats: Capital investment of ₹2,000 crore planned for expanding capacity in premium formats across home care, personal care, and beauty.
What are the key risks for HUL in FY27?
Key risks include Sustained crude inflation and currency depreciation — Crude-linked commodity costs and rupee depreciation could increase input costs beyond current 8-10% inflation, pressuring margins.; El Niño impact on rural demand — Below-normal monsoon forecast (92%) could affect rural incomes and demand, though reservoir levels and MSPs provide some buffer.; Competitive intensity limiting pricing power — If competitors do not follow price hikes, HUL may need to absorb cost inflation or lose market share, potentially impacting margins.; Mass skincare portfolio drag — Mass skincare (Glow & Lovely, talcum powders) remained subdued, weighing on overall beauty segment growth despite premium strength..
Did HUL meet its previous quarter's guidance?
Scorecard data is being built as historical quarters are processed.
Where can I read the full HUL Q4 FY26 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary verified against official BSE/NSE filings.